Lifestyle-related cancers, such as lung, colorectal, and skin cancers, have increased globally over the past decade, according to the most
Continue reading »
Learning from a cancer’s past could predict its future
Complaining about the weather is a favourite pastime for many. And while we can’t change it, the forecast gives us
Continue reading »
By forming clots in tumors, immune cell aids lung cancer’s spread
University of North Carolina Lineberger Comprehensive Cancer Center researchers have found that by helping to form clots within tumors, immune
Continue reading »
Lifestyle counseling program may reduce risk of certain cancers
A 5-year healthy lifestyle counseling program for adult men was linked with a reduced risk of developing cancers related to
Continue reading »
New regimens improve survival for children and young adults with T-cell cancers
In a federally funded, randomized phase III clinical trial performed by the Children’s Oncology Group (COG), 90 percent of children
Continue reading »
Deadly cancers show early, detectable differences from benign tumors
Do metastatic cancer tumors “break bad” or are they “born bad”? This question is an essential mystery in cancer early
Continue reading »
Molecular culprit behind virus-mediated chronic inflammation and cancers identified
Within cells infected by Kaposi sarcoma herpesvirus (KSHV), the human protein CADM1 interacts with viral proteins to promote chronic inflammation,
Continue reading »
Study may explain why some triple-negative breast cancers are resistant to chemotherapy
Triple-negative breast cancer (TNBC) is an aggressive form of the disease accounting for 12 to 18 percent of breast cancers.
Continue reading »
Males with BRCA mutations have increased risk of certain cancers
(HealthDay)—Males with BRCA mutations have increased incidence of malignant disease, specifically prostate, melanoma, pancreas, and breast cancers, according to a
Continue reading »
Two studies find resistance mechanisms in ALK+ and ROS1+ cancers
Targeted treatments have revolutionized care for lung cancer patients whose tumors harbor ALK or ROS1 alterations. Basically, cancers may use
Continue reading »